Martin R. Jefson

Chief Executive Officer at Pinteon Therapeutics, Inc.

Health Technology

Profile

Martin R.
Jefson is currently the Chief Executive Officer at Pinteon Therapeutics, Inc. He was previously the Chief Scientific Officer at Rodin Therapeutics, Inc. and Ataxion, Inc.

Martin R. Jefson active positions

Companies	Position	Start
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Chief Executive Officer	-

All active positions of Martin R. Jefson

Former positions of Martin R. Jefson

Companies	Position	End
Rodin Therapeutics, Inc. Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	-
Ataxion, Inc. Ataxion, Inc. BiotechnologyHealth Technology Ataxion, Inc. develops novel therapies for rare, debilitating, and underserved neurologic diseases. It focuses on orphan genetic disorders termed hereditary ataxias. It was founded by Josh Resnick and David Grayzel in April 2013 and is headquartered in Cambridge, MA.	Chief Tech/Sci/R&D Officer	-

See the detail of Martin R. Jefson's experience

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Martin R. Jefson's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	3
Ataxion, Inc. Ataxion, Inc. BiotechnologyHealth Technology Ataxion, Inc. develops novel therapies for rare, debilitating, and underserved neurologic diseases. It focuses on orphan genetic disorders termed hereditary ataxias. It was founded by Josh Resnick and David Grayzel in April 2013 and is headquartered in Cambridge, MA.	Health Technology
Rodin Therapeutics, Inc. Rodin Therapeutics, Inc. BiotechnologyHealth Technology Rodin Therapeutics, Inc. develops first in class therapeutics for cognitive disorders. The company was founded by Bruce Booth in 2013 and is headquartered in Cambridge, MA.	Health Technology
Pinteon Therapeutics, Inc. Pinteon Therapeutics, Inc. BiotechnologyHealth Technology Pinteon Therapeutics, Inc. develops cancer and CNS therapeutics. It focuses on the discovery and development of therapeutics targeting Pin1. The firm specializes in aberrant disease processes and improves patient outcomes in medical need indications. The company is headquartered in Newton Centre, MA.	Health Technology

See company connections

Stock Market
Insiders
Martin R. Jefson